The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
The NOS Inhibitor, 7-Nitroindazole, Decreases Focal Infarct Volume but Not the Response to Topical Acetylcholine in Pial Vessels
Open accessAbstract
We examined whether 7-nitroindazole (7-NI), a putative inhibitor of neuronal nitric oxide synthase (nNOS), decreases cerebral infarction 24 h after proximal middle cerebral artery (MCA) occlusion. In preliminary experiments, we determined that 7-NI (25, 50, and 100 mg/kg i.p.) decreased nitric oxide synthase (NOS) activity within cerebral cortex by 40–60% when measured up to 120 min, but not 240 min after administration. At 25 or 50 mg/kg, 7-NI did not alter the systemic arterial blood pressure or the dilation of pial arterioles after topical acetylcholine (10 and 100 μ M). To examine the effect of 7-NI on infarct size, 55 Sprague–Dawley halothaneanesthetized rats were subjected to proximal MCA occlusion (modified Tamura method). Five minutes after occlusion, 7-NI (25 or 50 mg/kg i.p.) or vehicle was injected. Animals treated with 25 or 50 mg/kg showed 25 and 27% reductions in infarct volume, respectively. Coadministration of l-arginine (300 mg/kg i.p.) plus 7-NI (25 mg/kg i.p.) reversed the effect. If, indeed, the effects of 7-NI are mediated by inhibition of nNOS activity, these results suggest that enzymatic products of the neuronal isoform promote ischemic injury and that they do so at least within the first few hours after permanent occlusion. The results also emphasize the importance of developing strategies to selectively inhibit the neuronal isoform inasmuch as we observed previously that administering the less selective NOS inhibitor, N ω -nitro-l-arginine (L-NA), in the same model either caused no change or increased the volume of ischemic injury.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In recent years, several studies have linked nitric oxide as a key mediator in numerous neurodegenerative diseases, such as Parkinson’s disease (PD), Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS), Huntington’s disease (HD) and ischemic brain injury (stroke).”
From The Role of Reactive Species on Innate Immunity (2022) · cites this paper as [145]
In the citing paper
“This dual action makes it a contributing player in pathophysiology, but also makes the development of effective treatments for neurodegenerative diseases particularly difficult [141,142,143,144,145].”
From The Role of Reactive Species on Innate Immunity (2022) · cites this paper as [145]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nitric oxide: physiology, pathophysiology, and pharmacology.
Moncada, S., Palmer, R. M., & Higgs, E. A. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06663-3 · Cited by 15,525
Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A., & Freeman, B. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1620 · Cited by 7,029
The L-Arginine-Nitric Oxide Pathway
Epstein, F. H., Moncada, S., & Higgs, A. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292706 · Cited by 6,678
Vascular endothelial cells synthesize nitric oxide from L-arginine
Palmer, R. M. J., Ashton, D., & Moncada, S. (1988) · Nature · doi:10.1038/333664a0 · Cited by 4,786
Bederson, J. B., Pitts, L. H., Tsuji, M., Nishimura, M. C., Davis, R. L., & Bartkowski, H. (1986) · Stroke · doi:10.1161/01.str.17.3.472 · Cited by 2,681
Peroxynitrite oxidation of sulfhydryls.
Radí, R., Beckman, J. S., Bush, K., & Freeman, B. Α. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)64313-7 · Cited by 2,492
Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures.
Dawson, V. L., Dawson, T. M., London, E. D., Bredt, D. S., & Snyder, S. H. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.14.6368 · Cited by 2,174
Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum.
Bredt, D. S., & Snyder, S. H. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.22.9030 · Cited by 1,849
Tamura, A., Graham, D., McCulloch, J., & Teasdale, G. M. (1981) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1981.6 · Cited by 1,432
Knowles, R. G., Palacios‐Callender, M., Palmer, R. M. J., & Moncada, S. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.13.5159 · Cited by 1,431
Flagged first, then by citations
Research works printed but not linked: 2
- Morikawa E, 1992, Am J Physiol, 263, H1,632
- Moskowitz MA, 1993, Microcirculatory Stasis in the Brain, 287
Cited by
Sorted by citations
Items 101–200 of 286
Ischemic injury and faulty gene transcripts in the brain
Liu, P. K., Grossman, R. G., Hsu, C. Y., & Robertson, C. S. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01918-4 · Cited by 62
Mechanisms of Cerebral Ischemic Damage
Iadecola, C. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-479-5_1 · Cited by 62
Two pathways of nitric oxide production through glutamate receptors in the rat cerebellum in vivo
Yamada, K., & Nabeshima, T. (1997) · Neuroscience Research · doi:10.1016/s0168-0102(97)00032-1 · Cited by 61
Effects of Mild Hypothermia on Nitric Oxide Synthesis Following Contusion Trauma in the Rat
SAKAMOTO, K.-I., Fujisawa, H., KOIZUMI, H., Tsuchida, E., Ito, H., Sadamitsu, D., & Maekawa, T. (1997) · Journal of Neurotrauma · doi:10.1089/neu.1997.14.349 · Cited by 61
Oxidative Damage to the c‐fos Gene and Reduction of Its Transcription After Focal Cerebral Ischemia
Cui, J., Holmes, E. H., & Liu, P. K. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0731164.x · Cited by 61
“…levels are known to be elevated after brain injury of the ischemia–reperfusion type (Hall and Braughler, 1989; Rosenthal et al., 1992; Poiries, 1994; Yoshida et al., 1994; Zhang et al., 1994; O’Neill et al., 1996; Smith et al., 1996) and following administration of excitotoxic drugs (Schulz et…”
BackgroundMethodResultInfluentialHuang, D., Shenoy, A., Cui, J., Huang, W.-Y., & Liu, P. K. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.2.407 · Cited by 60
Sleep and nitric: oxide: effects of 7-nitro indazole, inhibitor of brain nitric oxide synthase
Dzoljic, M., de Vries, R., & van Leeuwen, R. (1996) · Brain Research · doi:10.1016/0006-8993(96)00102-3 · Cited by 59
“) decreased the NOS activity within cerebral cortex of rat by 40 -60% when measured up to 120 min but not 240 min after administration [32].”
MethodMasahiro, N. I. W. A., Inao, S., Takayasu, M., 河合達巳, Kajita, Y., Nihashi, T., Kabeya, R., Sugimoto, T., & Yoshida, J. (2001) · Neurologia medico-chirurgica · doi:10.2176/nmc.41.63 · Cited by 58
Montécot, C., Rondi‐Reig, L., Springhetti, V., Seylaz, J., & Pinard, E. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00566-6 · Cited by 57
Neuroprotective effects of 7-nitroindazole in the gerbil model of global cerebral ischaemia
O’Neill, M. J., Hicks, C. A., & Ward, M. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00387-1 · Cited by 57
Wei, J., & Quast, M. J. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00089-4 · Cited by 56
Laude, K. M., Favre, J., Thuillez, C., & Richard, V. J. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00627.2002 · Cited by 56
“This dose was chosen on the basis that it effectively blocks brain nNOS in mice without functional evidence of eNOS inhibition (18) and also limits cerebral infarct size in rats (30).”
BackgroundIshida, A., Trescher, W. H., Lange, M. S., & Johnston, M. V. (2001) · Brain and Development · doi:10.1016/s0387-7604(01)00237-6 · Cited by 55
The potential of nitric oxide therapeutics in stroke
Willmot, M. R., & Bath, P. M. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.3.455 · Cited by 56
Nitric Oxide Synthase Expression after Human Brain Contusion
Gahm, C., Holmin, S., & Mathiesen, T. I. (2002) · Neurosurgery · doi:10.1097/00006123-200206000-00024 · Cited by 54
“Studies using selective nNOS inhibitors (30, 41, 45) or nNOS-knockout mice (10, 16) demonstrated reductions in cerebral ischemic damage.”
MethodHiguchi, Y., Hattori, H., Hattori, R., & Furusho, K. (1996) · Brain and Development · doi:10.1016/0387-7604(96)00019-8 · Cited by 54
“In adult rats as well, recent data show that a selective nNOS inhibitor decreases the infarct volume and suggest that the effects of eNOS can be discriminated from those of nNOS [29].”
Benavides, G. A., Liang, Q., Dodson, M. B., Darley-Usmar, V. M., & Zhang, J. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.09.006 · Cited by 53
“A pathological role for NO in brain ischemia-reperfusion has been suggested on the basis of both experiments in genetic models of NOS ablation and the use of NOS inhibitors (10-16).”
MethodInteraction between ATP-Sensitive K + Channels and Nitric Oxide on Pial Arterioles in Piglets
Bari, F., Errico, R. A., Louis, T. M., & Busija, D. W. (1996) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199611000-00010 · Cited by 52
Lee, H. J., Lyu, D. H., Koo, U., Nam, K.-W., Hong, S. S., Kim, K. O., Kim, K. H., Lee, D., & Mar, W. (2012) · Archives of Pharmacal Research · doi:10.1007/s12272-012-0118-7 · Cited by 51
“For example, inhibitors of neuronal nitric oxide synthase (nNOS) have been shown to significantly reduce lesions produced in response to focal ischemia (Yoshida et al., 1994) and mice that are deficient in the nNOS gene exhibit significant protection against cerebral ischemia (Huang et al.”
BackgroundCholet, N., Bonvento, G., & Seylaz, J. (1996) · Brain Research · doi:10.1016/0006-8993(95)01387-3 · Cited by 51
Siegel, C., & McCullough, L. D. (2010) · Acta Physiologica · doi:10.1111/j.1748-1716.2010.02229.x · Cited by 53
Nitric oxide synthase activity and inhibition after neonatal hypoxia ischemia in the mouse brain
Muramatsu, K., Sheldon, R. A., Black, S. M., Täuber, M. G., & Ferriero, D. M. (2000) · Developmental Brain Research · doi:10.1016/s0165-3806(00)00088-2 · Cited by 50
Cerebral microvascular dilation during hypotension and decreased oxygen tension: a role for nNOS
Bauser‐Heaton, H. D., & Bohlen, H. G. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00190.2007 · Cited by 50
O’Neill, M. J., Murray, T. K., McCarty, D. R., Hicks, C. A., Dell, C. P., Patrick, K. E., Ward, M., Osborne, D. J., Wiernicki, T. R., Roman, C. R., et al. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02471-9 · Cited by 50
Nitric Oxide and the Cardiovascular System
Bohlen, H. G. (2015) · Comprehensive physiology · doi:10.1002/cphy.c140052 · Cited by 54
Pinard, E., Engrand, N., & Seylaz, J. (2000) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200012000-00004 · Cited by 49
Elibol, B., Söylemezoğlu, F., Ünal, I., Fujii, M., Hirt, L., Huang, P. L., Moskowitz, M. A., & Dalkara, T. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00159-2 · Cited by 49
Self-citationLiu, P. K., Robertson, C. S., & Valadka, A. B. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04071.x · Cited by 48
Role of Nitric Oxide in Pathogenesis Underlying Ischemic Cerebral Damage
Matsui, T., Nagafuji, T., Kumanishi, T., & Asano, T. (1999) · Cellular and Molecular Neurobiology · doi:10.1023/a:1006985112459 · Cited by 47
“Yoshida et al. (1994) demonstrated the beneficial effects of 7-NI on permanent MCAo.”
BackgroundMethodEblen, F., Löschmann, P. A., Wüllner, U., Turski, L., & Klockgether, T. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00795-4 · Cited by 47
Nitric oxide synthase in cerebral ischemia
Nagafuji, T., Sugiyama, M., Matsui, T., Muto, A., & Naito, S. (1995) · Molecular and Chemical Neuropathology · doi:10.1007/bf02815009 · Cited by 47
篤史, 吉., Montécot, C., Sevestre, A., & Pichon, J. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03597-7 · Cited by 46
Liu, P. K. (2003) · Journal of Biomedical Science · doi:10.1007/bf02255992 · Cited by 44
Limiting Neurological Damage After Stroke
Read, S. J., Hirano, T., Davis, S. M., & Donnan, G. A. (1999) · Drugs & Aging · doi:10.2165/00002512-199914010-00002 · Cited by 43
Blockade of neuronal nitric oxide synthase alters the baroreflex control of heart rate in the rabbit
Murakami, H., Liu, J., Yoneyama, H., Nishida, Y., Okada, K., Kosaka, H., Morita, H., & Zucker, I. H. (1998) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1998.274.1.r181 · Cited by 43
“It has been shown that 7-NI administered at 50 mg/kg decreased NOS activity within the forebrain to 45% after 30 min (33).”
BackgroundLi, X., Nemoto, M., Xu, Z., Yu, S.-W., Shimoji, M., Andrabi, S. A., Haince, J.-F., Poirier, G. G., Dawson, T. M., Dawson, V. L., et al. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.08.065 · Cited by 42
“Because comparable doses of 7-NI do not inhibit endothelial-dependent dilation to acetylcholine (Yoshida et al., 1994), the effects of 7-NI are considered to be selective for nNOS.”
BackgroundOhyu, J., & Takashima, S. (1998) · Developmental Brain Research · doi:10.1016/s0165-3806(98)00107-2 · Cited by 42
Chapter 16 Mechanisms of NO neurotoxicity
Dalkara, T., Endres, M., & Moskowitz, M. A. (1998) · Progress in brain research · doi:10.1016/s0079-6123(08)63211-2 · Cited by 41
Self-citationLei, B., Adachi, N., Nagaro, T., & Arai, T. (1999) · Stroke · doi:10.1161/01.str.30.3.669 · Cited by 40
Alabadí, J. A., Thibault, J.-L., Pinard, E., Seylaz, J., & Lasbennes, F. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01749-7 · Cited by 38
Chapter 14 Neurotoxic and Neuroprotective Roles of Nitric Oxide in Cerebral Ischaemia
Dalkara, T., & Moskowitz, M. A. (1996) · International review of neurobiology · doi:10.1016/s0074-7742(08)60726-6 · Cited by 38
Self-citationMésenge, C., VERRECCHIA, C., Allix, M., Boulu, R. G., & Plotkine, M. (1996) · Journal of Neurotrauma · doi:10.1089/neu.1996.13.209 · Cited by 37
Schwarz, P. M., Gierten, B., Boissel, J., & Förstermann, U. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.2.258 · Cited by 37
“Similarly, the NOS inhibitor 7-nitroindazole, which exhibits a certain specificity for NOS I in vivo, reduced cerebral ischemic damage in rats caused by proximal middle cerebral artery occlusion (Yoshida et al., 1994).”
BackgroundCoert, B. A., Anderson, R. E., & Meyer, F. B. (1999) · Journal of neurosurgery · doi:10.3171/jns.1999.90.2.0332 · Cited by 37
Hu, Y. F., & Zhu, D. (2014) · Vitamins and hormones · doi:10.1016/b978-0-12-800254-4.00006-4 · Cited by 36
Krupiński, J., Yoram Vodovotz, B., Li, C., Słowik, A., Beevers, D., Flanders, K. C., Lip, G. Y. H., Kumar, P., & Szczudlik, A. (1998) · Nitric Oxide · doi:10.1006/niox.1998.0204 · Cited by 36
Sato, T., MORISHIMA, Y., Sugimura, M., Uchida, T., & Shirasaki, Y. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00133-8 · Cited by 36
Die, J., Wang, K., Fan, L., Jiang, Y., & Shi, Z. (2010) · Brain Research · doi:10.1016/j.brainres.2010.05.068 · Cited by 35
Changes in pro-oxidant and antioxidant enzyme levels during cerebral hypoperfusion in rats
Mracsko, E. Z., Hugyecz, M., Institóris, Á., Farkas, E., & Bari, F. (2009) · Brain Research · doi:10.1016/j.brainres.2009.11.080 · Cited by 35
Tjong, Y.-W., Jian, K., Li, M., Chen, M., Gao, T., & Fung, M. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.09.020 · Cited by 35
“It has also been shown that blockade of the activity of nitric oxide synthases (NOSs) ameliorates neuronal injuries following severe hypoxia or ischemia in animal models [4,5], brain slices [6–8], and cultured neurons [9,10].”
BackgroundMaturation-dependent apoptotic cell death of oligodendrocytes in myelin-deficient rats
Grinspan, J. B., Coulalaglou, M., Beesley, J., Carpio, D. F., & Scherer, S. S. (1998) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19981201)54:5 · Cited by 33
Discovery and development of neuronal nitric oxide synthase inhibitors
Reif, D. W., McCarthy, D. J., CREGAN, E. F., & Macdonald, J. E. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00250-1 · Cited by 34
Ayajiki, K., Fujioka, H., Okamura, T., & Toda, N. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01068-8 · Cited by 34
Putzke, J., Seidel, B., Huang, P. L., & Wolf, G. L. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00220-5 · Cited by 34
Oka, M., Hirouchi, M., Itoh, Y., & Ukai, Y. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00197-5 · Cited by 34
Tissue kallikrein alleviates glutamate‐induced neurotoxicity by activating ERK1
Liu, L., Zhang, R., Liu, K., Zhou, H., Tang, Y., Su, J., Yu, X., Yang, X., Tang, M., & Dong, Q. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22151 · Cited by 33
“…playing a detrimental role in ischemic damage and glutamate neurotoxicity and selective inhibition of nNOS with 7-NI has been reported to attenuate both ischemic injury and the excitotoxic lesions produced by NMDA (Dawson et al., 1991; Yoshida et al., 1994; Huang et al., 1994; Schulz et al., 1995).”
BackgroundNeill, M. J., Hicks, C. A., Ward, M., & Panetta, J. A. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00293-x · Cited by 33
Romero‐Grimaldi, C., Gheusi, G., Lledo, P., & Estrada, C. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.05127.x · Cited by 32
“The relatively specific nNOS inhibitor 7-nitroindazole (7-NI) was also administered for 4 days, at doses reported to significantly decrease cerebral NOS activity (30 mg ⁄ kg, i.p.) (Yoshida et al., 1994).”
BackgroundYuan, Z., Liu, W., Liu, B., Schnell, A., & Liu, K. J. (2010) · Brain Research · doi:10.1016/j.brainres.2010.07.010 · Cited by 30
“Moreover, pharmacologically selective nNOS inhibitors (Yoshida et al. 1994; Zhang et al. 1996b) or nNOS knockout (Ferriero et al. 1996; Panahian et al. 1996) attenuate the infarction volume after focal cerebral ischemia.”
BackgroundMethodInfluentialSnider, B. J., Choi, J., Turetsky, D. M., Canzoniero, L. M. T., Sensi, S. L., Sheline, C. T., Wang, X., Yu, S. P., & Choi, D. W. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00311-0 · Cited by 30
VERRECCHIA, C., Boulu, R. G., & Plotkine, M. (1995) · Advances in Neuroimmunology · doi:10.1016/0960-5428(95)00023-2 · Cited by 30
Haga, K. K., Gregory, L. J., Hicks, C. A., Ward, M., Beech, J. S., Bath, P. M., Williams, S., & O’Neill, M. J. (2003) · Brain Research · doi:10.1016/j.brainres.2003.08.063 · Cited by 30
Adachi, N., Lei, B., SOUTANI, M., & Arai, T. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01222-2 · Cited by 30
Kahn, R. A., Panah, M. H., & Weinberger, J. M. (1997) · Anesthesia & Analgesia · doi:10.1097/00000539-199705000-00009 · Cited by 30
Groenendaal, F., de Graaf, R. A., van Vliet, G., & Nicolay, K. (1999) · Pediatric Research · doi:10.1203/00006450-199906000-00008 · Cited by 29
Fujisawa, H., KOIZUMI, H., Ito, H., Yamashita, K., & Maekawa, T. (1999) · Journal of Neurotrauma · doi:10.1089/neu.1999.16.1083 · Cited by 28
Influence of 7-nitroindazole on the anticonvulsive action of conventional antiepileptic drugs
Borowicz, K. K., Kleinrok, Z., & Czuczwar, S. J. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01034-0 · Cited by 28
Oka, M., Itoh, Y., & Ukai, Y. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39264-x · Cited by 28
Functional importance of neuronal nitric oxide synthase in the endothelium of rat basilar arteries
Benyó, Z., Lacza, Z., Hortobágyi, T., Görlach, C., & Wahl, M. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02611-1 · Cited by 26
Iohom, G., Szarvas, S., Larney, V., O’Brien, J., Buckley, E., Butler, M. D., & Shorten, G. (2004) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000132971.00206.4a · Cited by 26
iNOS contribution to the NMDA‐induced excitotoxic lesion in the rat striatum
Lecanu, L., VERRECCHIA, C., Margaill, I., Boulu, R. G., & Plotkine, M. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702119 · Cited by 26
“It has been shown that NO derived from neuronal NOS has a deleterious e ect during the early phase of ischaemic brain injury (Yoshida et al., 1994).”
BackgroundJiang, M. H., Kaku, T., Hada, J., & Hayashi, Y. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00555-5 · Cited by 26
The Role of Nitric Oxide in the Cerebrovascular Response to Hypercapnia
Smith, J. J., Lee, J. G., Hudetz, A. G., Hillard, C. J., Bosnjak, Z. J., & Kampine, J. P. (1997) · Anesthesia & Analgesia · doi:10.1097/00000539-199702000-00023 · Cited by 24
Royes, L. F. F., Fighera, M. R., Furian, A. F., Oliveira, M. S., Fiorenza, N. G., Myskiw, J. D. C., Frussa‐Filho, R., & Mello, C. F. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.11.038 · Cited by 24
Proabsorptive and prosecretory roles for nitric oxide in cholera toxin induced secretion
Turvill, J. L., Mourad, F. H., & Farthing, M. J. G. (1999) · Gut · doi:10.1136/gut.44.1.33 · Cited by 24
Hirabayashi, H., Takizawa, S., Fukuyama, N., Nakazawa, H. K., & Shinohara, Y. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00368-7 · Cited by 24
Mao, L., Zhou, Q., Zhou, S., Wilbur, R. R., & Li, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058168 · Cited by 23
“A possible explanation could be that cNOS(eNOS and nNOS) is considered as the primary source of NO which plays an important role in the regulation of systemic blood pressure, blood flow and regional vascular tone in physiological condition [25,44].”
BackgroundMechanisms mediating NG-nitro-l-arginine methyl ester-induced hypophagia in mice
Hui, S. G., & Chan, T. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00312-9 · Cited by 22
Nitric oxide inhibitors attenuate ischemic degeneration in the CA1 region of rat hippocampal slices
Izumi, Y., Benz, A. M., Clifford, D. B., & Zorumski, C. F. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)12669-0 · Cited by 23
Nitric Oxide: Physiological Roles, Biosynthesis and Medical Uses
Adams, D. R., Brochwicz‐Lewinski, M., & BUTLER, A. R. (1999) · Fortschritte der Chemie Organischer Naturstoffe/Fortschritte der Chemie organischer Naturstoffe/Progress in the chemistry of organic natural products · doi:10.1007/978-3-7091-6351-1_1 · Cited by 23
Wilderman, M. J., & Armstead, W. M. (1997) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1997.273.4.h1807 · Cited by 22
7-Nitroindazole Inhibits Pial Arteriolar Vasodilation in a Rat Model of Pneumococcal Meningitis
Paul, R. H., Koedel, U., & Pfister, H. (1997) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199709000-00008 · Cited by 22
Zhang, Y., Boddicker, K. A., Rhee, B. J., Davies, L. R., & Kerber, R. E. (2005) · Resuscitation · doi:10.1016/j.resuscitation.2005.03.015 · Cited by 22
Nitric Oxide Deficiency Contributes to Large Cerebral Infarct Size
Kidd, G. A., Dobrucki, L. W., Brovkovych, V. M., Bohr, D. F., & Maliñski, T. (2000) · Hypertension · doi:10.1161/01.hyp.35.5.1111 · Cited by 21
Hicks, C. A., Ward, M., Swettenham, J. B., & O’Neill, M. J. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00543-9 · Cited by 21
Dual Role for Nitric Oxide in Dynorphin Spinal Neurotoxicity
Hu, W., Li, F., Qiang, W., Liu, N., WANG, G.-Q., Xiao, J., LIU, J.-S., Liao, W.-H., & Jen, M.-F. (1999) · Journal of Neurotrauma · doi:10.1089/neu.1999.16.85 · Cited by 21
“…and iNOS (aminoguani-dine, AG) have been consistently demonstrated to ameliorate cerebral ischémie damage (Huang et al., 1994; Moore et al., 1994; Yoshida et al., 1994; Iadecola et al., 1995b, Zhang et al., 1996), traumatic brain injury (Mesenge et al., 1996), and striatal malonate lesion…”
Prior exposure to enriched environment reduces nitric oxide synthase after transient MCAO in rats
Yu, K., Wu, Y., Hu, Y., Zhang, Q., Xie, H., Liu, G., Chen, Y., Guo, Z., & Jia, J. (2013) · NeuroToxicology · doi:10.1016/j.neuro.2013.09.002 · Cited by 20
Miyazaki, H., Tanaka, S., Fujii, Y., Shimizu, K., Nagashima, K., Kamibayashi, M., Uehara, T., Okuma, Y., & Nomura, Y. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00011-9 · Cited by 20
The Role of Nitric Oxide in the Cerebrovascular Response to Hypercapnia
Smith, J. J., Lee, J. G., Hudetz, A. G., Hillard, C. J., Bosnjak, Z. J., & Kampine, J. P. (1997) · Anesthesia & Analgesia · doi:10.1213/00000539-199702000-00023 · Cited by 20
Is neuroprotective efficacy of nNOS inhibitor 7-NI dependent on ischemic intracellular pH?
Coert, B. A., Anderson, R. E., & Meyer, F. B. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00580.2002 · Cited by 19
“The dosages used in this study were based on our previous study (17) and those of the literature (35, 67).”
BackgroundMethodInfluentialWalkowska, A., Kompanowska‐Jezierska, E., & Sadowski, J. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00792.x · Cited by 19
Matter, H., & Kotsonis, P. (2004) · Medicinal Research Reviews · doi:10.1002/med.20005 · Cited by 19
“Furthermore the NOS-I selective inhibitor 7-nitroindazole showed reduced infarct sizes in animal models of focal ischemia, whereas non selective ligands did not show this effect.(37)”
MethodIzumi, Y., Katsuki, H., Benz, A. M., & Zorumski, C. F. (1998) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199801000-00010 · Cited by 19
Cui, J., & Liu, P. K. (2001) · Journal of Biomedical Science · doi:10.1007/bf02258375 · Cited by 19
Kohno, K., Ohta, S., Furuta, S., Kohno, K., Kumon, Y., & Sakaki, S. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)12018-y · Cited by 19
Involvement of Nitric Oxide From Nerves on Diarrhea Induced by Castor Oil in Rats
Uchida, M., Kato, Y., Matsueda, K., Shoda, R., Muraoka, A., & Yamato, S. (2000) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.82.168 · Cited by 18
Greenberg, J. H., Sohn, N., & Hand, P. J. (1999) · Experimental Brain Research · doi:10.1007/s002210050924 · Cited by 18
Der dreiwertige Neodymiumkomplex [(C5Me5)3Nd] ist ein Ein-Elektronen-Donor!
Evans, W. J., Nyce, G. W., Clark, R. D., Doedens, R. J., & Ziller, J. W. (1999) · Angewandte Chemie · doi:10.1002/(sici)1521-3757(19990614)111:12 · Cited by 7
Čačányiová, S., Kristek, F., Gerová, M., Křenek, P., & Klimas, J. (2009) · Nitric Oxide · doi:10.1016/j.niox.2009.03.002 · Cited by 18
Chapter 23. Nitric Oxide Synthase Inhibitors
Macdonald, J. E. (1996) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(08)60462-5 · Cited by 18
Metadata
- Authors
- Yoshida, T., Limmroth, V., Irikura, K., & Moskowitz, M. A.
- Affiliations
- Harvard University (US)
- Venue
- Journal of Cerebral Blood Flow & Metabolism
- Publisher
- SAGE Publications
- Published
- 1994-11
- Volume
- 14
- Issue
- 6
- Pages
- 924-929
- ISSN
- 0271-678X (ISSN-L)
- 1559-7016
- OpenAlex
- W2047362612
- Cited by
- 286
- References
- 34
- Citations by year
- 2024: 2 · 2022: 2 · 2021: 1 · 2020: 1 · 2019: 1 · 2018: 2 · 2017: 4 · 2016: 1 · 2015: 3 · 2014: 6 · 2013: 3 · 2012: 3
- FWCI
- 16.29
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Cerebral Blood Flow & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ns021558-09)
- National Institute of Neurological Disorders and Stroke (NS-21558, NS 64361)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
- Keywords
- 7-nitroindazole, neuronal nitric oxide synthase, nitric oxide, cerebral ischemia, middle cerebral artery occlusion, infarct size, L-arginine, nitric oxide synthase inhibitors, L-NAME, cerebral vasodilation
- MeSH terms
- Acetylcholine, Administration, Topical, Amino Acid Oxidoreductases, Animals, Brain, Cerebral Infarction, Cerebrovascular Circulation, Indazoles, Male, Pia Mater, Rats, Sprague-Dawley, Nitric Oxide Synthase, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review